Safety and Efficacy Evaluation of Pleconaril for Treatment of the Common Cold [3]

Clinical Infectious Diseases

Volumn 37, Issue 12, 2003, Pages 1722-

  Fleischer, Russell ^a,b   Laessig, Katherine ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b HFD 530   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PLECONARIL;

COMMON COLD; CONVALESCENCE; DRUG ANTAGONISM; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MENSTRUATION DISORDER; PREGNANCY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT FAILURE; VIRUS RESISTANCE;

EID: 0346848719     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379830     Document Type: Letter

References (2)

1. Hayden FG, Herrington DT, Coats TL, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003; 36:1523-32.
2. US Food and Drug Administration. Transcripts of the 19 March 2002 Antiviral Drugs Advisory Committee meeting. Available at: http://www .fda.gov/ohrms/dockets/ac/cder02.htm#anti viraldrugs. Accessed on 29 September 2003.